Products

Molecule name Strengths Therapy Innovator & Brand Product used for BE Studies Territories where the product is
registered (MAs in the names of
marketing partners)		 Territories where the product is under registration
Telmisartan Amlodipine tablets 80/10 mg,
80/5 mg,
40/10 mg,
40/5 mg		 Anti-Hypertension Boehringer Ingelheim - TWYNSTA Australia, Vietnam, Philippines, Ukraine, Peru, UAE Malaysia, ZaZiBoNa, Paraguay, Myanmar, Chile, UAE, UK
Carbidopa + Levodopa IR tablets 25/250 mg, 25/100mg,
10/100 mg,
12.5/50 mg		 Parkinson’s disease Merck & Dohme – SINEMET
Merck & Dohme – SINEMET PLUS		 Portugal, Ireland, Czech Republic, Denmark, Canada, Australia, Germany, Spain, Poland, New Zealand, Vietnam, Paraguay Philippines, Myanmar,
ZaZiBoNa, South Africa, Saudi Arabia, UK, Costa Rica
Carbidopa + Levodopa ER tablets 50/200 mg Parkinson’s disease Merck & Dohme - SINEMET CR
Impax Laboratories – RYTARY		 - ZaZiBoNa, Costa Rica
Telmisartan tablets 20 mg,
40 mg,
80 mg		 Anti-Hypertension Boehringer Ingelheim – MICARDIS Australia, UK, Czech Republic, Spain, Hungary, Poland, Romania, Philippines, Slovakia, Peru, Paraguay Vietnam, UK, Zimbabwe, Chile
Telmisartan + HCTZ tablets 80/25 mg,
80/12.5 mg,
40/12.5 mg		 Anti-Hypertension Boehringer Ingelheim - MICARDIS PLUS Australia, Philippines,
Vietnam, Paraguay, Peru		 Poland, Hungary, Myanmar, Paraguay, UK, Chile, Zimbabwe
Raloxifene tablets 60 mg Osteoporosis Daiichi Sankyo – EVISTA UK, Spain, Vietnam, Kazakhstan Philippines, UK, Saudi Arabia, Philippines
Levocetirizine tablets 5 mg Anti-histamine UCB – XYZAL - Chile, ZaZiBoNa, Hungary
Cetirizine tablets 10mg Anti-histamine UCB – ZYRTEC Germany, Australia, Canada, UK, Vietnam Chile, Ukraine, UK
Azithromycin Capsules 250 mg, 500 mg Anti-infective Pfizer- Zithromax Capsules UK Philippines, Vietnam
Azithromycin Tablets 250 mg, 500 mg Anti-infective Pfizer- Zithromax Tablets UK -
Metformin IR tablets 500 mg, 850 mg, 1000 mg Anti-Diabetic Merck - Glucopage - UK, Vietnam, Myanmar, Ukraine
Paroxetine tablets 20 mg Anti-Depressant Paxil - Vietnam
Amlodipine tablets 5 mg, 10 mg Anti-Hypertensive Pfizer - Istin - Vietnam
Olmesartan tablets 10 mg, 20 mg,
40 mg		 Anti-Hypertension Daiichi Sankyo – OLMETEC Philippines Myanmar, Peru
Olmesartan + HCTZ tablets 20/25 mg,
40/25 mg,
40/12.5 mg,
20/12.5 mg		 Anti-Hypertension Daiichi Sankyo - Co Olmetec
Daiichi Sankyo - Benicar HCT
Daiichi Sankyo - Olmetec Plus		 - Philippines, Myanmar, Vietnam, Peru

MA’s Held by Evertogen in UK, EU

Molecule name Ingredients Therapy Region Countries
Telmisartan+Amlodipine Tablets
40/5, 80/5, 40/10, 80/10 mg		 Telmisartan and Amlodipine Besylate Anti-Hypertension EU Hungary
Telmisartan Tablets
20, 40, 80 mg		 Telmisartan Anti-Hypertension EU Germany, Belgium, Ireland, Netherland, Portugal
Amlodipine Tablets
5, 10 mg		 Amlodipine Besylate Anti-Hypertensive EU, UK Austria, Spain, Ireland, UK, Poland, Portugal
Cetirizine Tablets
10mg		 Cetirizine Anti-Histamine EU Poland, Portugal
Levocetirizine Tablets
5mg		 Levocetirizine Anti-Histamine EU, UK Germany, Poland, Portugal, UK
Paroxetine Tablets
20mg		 Paroxetine Anti-Depressant UK UK

Products in the pipeline

Molecule name Ingredients Therapy Current Stage of Development Dossier Availability
Clopidogrel tablets Clopidogrel Bisulphate Anti-Platelet BE Study Scheduled in Q2CY24 Q3CY24
Hydroxyzine Hydrochloride tablets Hydroxyzine Hydrochloride Anti-Histamine R&D in progress Q4CY24
Montelukast + Levocetrizine tablets Montelukast, Levocetirizine Anti-Histamine R&D in progress Q4CY24
Apixaban Tablet Apixaban Anti-Platelet Complete dossier without BE study available, BE study scheduled before December 2024 Q4CY24
Dimethyl Fumarate Capsule Dimethyl Fumarate Immunomodulators Complete dossier without BE study available, BE study scheduled before December 2024 Q4CY24
Esomeprazole Delayed Release Tablets Esomeprazole PPI's R&D in progress Q1CY25
Clopidogrel tablets Clopidogrel Anti- Platelet Development completed, Awaiting Bio-study results. Q4 CY 25
Montelukast + Levocetirizine tablets Montelukast, Levocetirizine Anti-Histamine Under Development, Method validations under progress, Biostudy to be planned. Q1 CY 26
Apixaban Tablets Apixaban Anti- Platelet Development completed, Biostudy to be planned. Q1 CY 26